Bergeron, J.; Capo-Chichi, J.-M.; Tsui, H.; Mahe, E.; Berardi, P.; Minden, M.D.; Brandwein, J.M.; Schuh, A.C.
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Curr. Oncol. 2023, 30, 10410-10436.
https://doi.org/10.3390/curroncol30120759
AMA Style
Bergeron J, Capo-Chichi J-M, Tsui H, Mahe E, Berardi P, Minden MD, Brandwein JM, Schuh AC.
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current Oncology. 2023; 30(12):10410-10436.
https://doi.org/10.3390/curroncol30120759
Chicago/Turabian Style
Bergeron, Julie, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D. Minden, Joseph M. Brandwein, and Andre C. Schuh.
2023. "The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus" Current Oncology 30, no. 12: 10410-10436.
https://doi.org/10.3390/curroncol30120759
APA Style
Bergeron, J., Capo-Chichi, J.-M., Tsui, H., Mahe, E., Berardi, P., Minden, M. D., Brandwein, J. M., & Schuh, A. C.
(2023). The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current Oncology, 30(12), 10410-10436.
https://doi.org/10.3390/curroncol30120759